Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Podrid

Showing results (51-60 of 104) with videos related to

Pageof 11
Sort By:
American Heart Journal|May 1, 1985
Side effects and complications of amiodarone therapyE A Raeder, P J Podrid, B Lown
The New England Journal of Medicine|November 5, 1981
Prognosis of medically treated patients with coronary-artery disease with profound ST-segment depression during exercise testingP J Podrid, T B Graboys, B Lown
American Heart Journal|April 1, 1988
Intravenous lorcainide for symptomatic ventricular tachyarrhythmias: comparison with lidocaine and oral lorcainideS H Hohnloser, P J Podrid, B Lown
American Heart Journal|October 1, 1983
Efficacy of amiodarone for refractory supraventricular tachyarrhythmiasT B Graboys, P J Podrid, B Lown
Cardiology Clinics|August 1, 1992
Evaluating patients with ventricular arrhythmia. Role of the signal-averaged electrocardiogram, exercise test, ambulatory electrocardiogram, and electrophysiologic studiesP J Podrid, F Bumio, R I Fogel
The American Journal of Cardiology|June 4, 1992
Ventricular arrhythmia in congestive heart failureP J Podrid, R I Fogel, T T Fuchs
The American Journal of Cardiology|March 15, 1989
Effect of age on antiarrhythmic drug efficacy and toxicityP J Podrid, P A Levine, M P Klein
Journal of the American College of Cardiology|May 1, 1991
Role of combination drug therapy with a class IC antiarrhythmic agent and mexiletine for ventricular tachycardiaL Mendes, P J Podrid, T Fuchs, et al.
The American Journal of Cardiology|November 15, 1996
Should physicians participate in affirming the best approach to atrial fibrillation management?M A Brodsky, P J Podrid, J G Chun
American Heart Journal|June 1, 1989
Encainide and flecainide: are they interchangeable?V Saini, P J Podrid, W Slater, et al.
Pageof 11

Showing results (51-60 of 104) with videos related to

Sort By:
Pageof 11
American Heart Journal|May 1, 1985
Side effects and complications of amiodarone therapyE A Raeder, P J Podrid, B Lown
The New England Journal of Medicine|November 5, 1981
Prognosis of medically treated patients with coronary-artery disease with profound ST-segment depression during exercise testingP J Podrid, T B Graboys, B Lown
American Heart Journal|April 1, 1988
Intravenous lorcainide for symptomatic ventricular tachyarrhythmias: comparison with lidocaine and oral lorcainideS H Hohnloser, P J Podrid, B Lown
American Heart Journal|October 1, 1983
Efficacy of amiodarone for refractory supraventricular tachyarrhythmiasT B Graboys, P J Podrid, B Lown
Cardiology Clinics|August 1, 1992
Evaluating patients with ventricular arrhythmia. Role of the signal-averaged electrocardiogram, exercise test, ambulatory electrocardiogram, and electrophysiologic studiesP J Podrid, F Bumio, R I Fogel
The American Journal of Cardiology|June 4, 1992
Ventricular arrhythmia in congestive heart failureP J Podrid, R I Fogel, T T Fuchs
The American Journal of Cardiology|March 15, 1989
Effect of age on antiarrhythmic drug efficacy and toxicityP J Podrid, P A Levine, M P Klein
Journal of the American College of Cardiology|May 1, 1991
Role of combination drug therapy with a class IC antiarrhythmic agent and mexiletine for ventricular tachycardiaL Mendes, P J Podrid, T Fuchs, et al.
The American Journal of Cardiology|November 15, 1996
Should physicians participate in affirming the best approach to atrial fibrillation management?M A Brodsky, P J Podrid, J G Chun
American Heart Journal|June 1, 1989
Encainide and flecainide: are they interchangeable?V Saini, P J Podrid, W Slater, et al.
Pageof 11